Prostate-specific antigen density

Urologic Clinics of North America

Volumn 24, Issue 2, 1997, Pages 323-332

  Beduschi, M C ^a   Oesterling, J E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FINASTERIDE; PROSTATE SPECIFIC ANTIGEN;

AGE; ANTIGEN DETECTION; BLOOD LEVEL; CANCER SCREENING; CANCER STAGING; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; HUMAN; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVIEW; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0030935343     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70379-7     Document Type: Article

References (61)

1. A. Akdas T. Tarcan L. Turkeri The diagnostic accuracy of digital rectal examination, transrectal ultrasonography, prostate specific antigen and PSA density in prostate carcinoma Br J Urol 76 1995 54
2. A. Akdas T. Tarcan L. Turkeri The impact of prostate-specific antigen density in predicting prostate cancer when serum prostate-specific antigen levels are less than 10 ng/ml Eur Urol 29 1996 189
3. G.L. Andriole D. Coplen W.B. Catalona Serum PSA index (PSAI) as a staging tool for patients with otherwise clinically localized prostate cancer (CaP) [abstract 317] J Urol 147 1992 292A
4. R.J. Babaian H. Miyashita R.B. Evans The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: Relationship to gland volume and age J Urol 147 1992 837
5. R.J. Babaian H.A. Fritsche R.B. Evans Prostate specific antigen and the prostate gland volume: Correlation and clinical application J Clin Lab Anal 4 1990 135
6. M. Bazinet A.A. Meshref C. Trudel Prospective evaluation of prostate specific antigen density and systematic biopsies for early detection of prostatic carcinoma Urology 43 1994 44
7. M.C. Benson K.S. Ring C.A. Olsson The determination of stage D-0 carcinoma of the prostate utilizing PSA September 1989 Urologist's Correspondence Club
8. M.C. Benson I.S. Whang C.A. Olsson The use of prostate specific antigen density (PSAD) to enhance the predictive value of intermediate levels of serum PSA J Urol 147 1992 817
9. M.C. Benson I.S. Whang A. Pontuk Prostate specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer J Urol 147 1992 815
10. M.K. Brawer P.H. Lange PSA in the screening, staging, and follow-up of early prostate cancer: A review of recent developments World J Urol 7 1989 7
11. M.K. Brawer E.A.G. Aramburu G.L. Chen The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma J Urol 150 1993 369
12. M.K. Brawer M.P. Chetner J. Beatie Screening for prostatic carcinoma with prostate specific antigen J Urol 147 1992 841
13. P.R. Bretton W.P. Evans J.D. Borden The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma Cancer 74 1994 2991
14. H.B. Carter J.D. Pearson E.J. Metter Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease JAMA 267 1992 2215
15. W.J. Catalona M.A. Hudson P.T. Scardino Selection of optimal prostate specific antigen cuttoffs for early detection of prostate cancer: Receiver operating characteristics curves J Urol 152 1994 2037
16. W.J. Catalona J.P. Ritchie F.R. Ahmann Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men J Urol 151 1994 1283
17. W.J. Catalona D.S. Smith T.L. Ratliff Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N Engl J Med 324 1991 1156
18. W.J. Catalona D.S. Smith R.L. Wolfert Evaluation of the percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening JAMA 274 1995 124
19. D.W. Chan D.J. Bruzek J.E. Oesterling Prostate specific antigen as a marker for prostatic cancer: A monoclonal and polyclonal immunoassay compared Clin Chem 33 1987 1916
20. M.S. Cookson M.K. Floyd T.P. Ball The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels J Urol 154 1995 1070
21. W.H. Cooner Prostate-specific antigen, digital rectal examination, and transrectal ultrasonic examination of the prostate in prostate cancer detection Monogr Urol 12 1991 3
22. W.H. Cooner B.R. Mosley C.L. Rutherford Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer J Urol 139 1988 758
23. W.H. Cooner B.R. Mosley C.L. Rutherford Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination, and prostate specific antigen J Urol 143 1990 1146
24. B.W. Corn G.E. Hanks R.W. Lee Prostate specific antigen density is not an independent predictor of response for prostate cancer treated by conformal radiotherapy J Urol 153 1995 1855
25. E.D. Crawford E.P. DeAntoni PSA as a screening test for prostate cancer Urol Clin North Am 20 1993 637
26. R.E.S. El-Galley J.A. Petros W.A. Sanders Normal range prostate specific antigen versus age specific prostate specific antigen in screening prostate adenocarcinoma Urology 46 1995 200
27. C.J. Ercole P.H. Lange M. Mathisen Prostate specific antigen and prostatic acid phosphatase in the monitoring and staging of prostate cancer J Urol 138 1987 1181
28. W.J. Glenski R.S. Malek J.F. Myrtle Sustained substantially increased concentration of prostate specific-antigen in the absence of prostatic malignant disease: An unusual clinical scenario Mayo Clin Proc 67 1992 249
29. G.J. Gormley E. Stoner R. Bruskewitz The effect of finasteride on men with benign prostatic hyperplasia N Engl J Med 327 1992 1185
30. G.J. Gormley E. Stoner H. Guess Effect of finasteride on prostate-specific antigen density Urology 43 1994 53
31. H.A. Guess J.F. Heyse G.J. Gormley The effect of finasteride on prostate-specific antigen in men with benign prostatic hyperplasia Prostate 22 1993 31
32. H.A. Guess J.F. Heyse G.J. Gormley Effect of finasteride on serum PSA concentration in men with benign prostatic hyperplasia: Results from the North American Phase III Clinical Trial Urol Clin North Am 20 1993 627
33. P. Guinan R. Bhatti P. Ray An evaluation of prostate specific antigen in prostatic cancer J Urol 137 1987 686
34. M. Hara T. Inorre T. Fukuyama Some physico-chemical characteristics of gamma-seminoprotein, an antigenic component specific for human seminal plasma Japanese Journal of Legal Medicine 5 1971 322
35. M.A. Hudson R.R. Bahnson W.J. Catalona Clinical use of prostate specific antigen in patients with prostate cancer J Urol 142 1989 1011
36. K. Imai Y. Ichinose Y. Kubota Diagnostic significance of prostate specific antigen and the development of a mass screening system for prostate cancer J Urol 154 1995 1085
37. J. Kalish W.H. Cooner S.D. Graham Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate Urology 43 1994 601
38. P.H. Lange M.K. Brawer Serum prostate-specific antigen: Its use in diagnosis and management of prostate cancer Urology 33 suppl 1989 13
39. T.S. Li C.G. Beling Isolation and characterization of two specific antigen of human seminal plasma Fretil Steril 24 1973 134
40. A.W. Meshref M. Bazinet C. Trudel Role of prostate-specific antigen density after applying age-specific prostate-specific antigen references ranges Urology 45 1995 972
41. M. Nishiya C.J. Miller D.H. Lookner Prostate specific antigen density in patients with histologically proven prostate carcinoma Cancer 74 1994 3002
42. J.E. Oesterling Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate J Urol 145 1991 907
43. J.E. Oesterling D.W. Chan J.I. Epstein Prostate specific antigen in the preoperative and postoperative evaluation of localized prostate cancer treated with radical prostatectomy J Urol 139 1988 766
44. J.E. Oesterling W.H. Cooner S.J. Jacobsen Influence of patient age on serum PSA concentration Urol Clin North Am 20 1993 671
45. J.E. Oesterling S.J. Jacobsen C.G. Chute Serum prostate-specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges JAMA 270 1993 860
46. A.W. Partin J.E. Oesterling The clinical usefulness of prostate specific antigen: Update J Urol 143 1994 1358
47. A.W. Partin H.B. Carter D.W. Chan Prostate specific antigen in the staging of localized prostate cancer: Influence of tumor differentiation, tumor volume, and benign hyperplasia J Urol 143 1990 747
48. A. Pollack S. Lankford G.K. Zagars Prostate specific antigen density as a prognostic factor for patients with prostate carcinoma treated with radiotherapy Cancer 77 1996 1515
49. J.M. Robles A.R. Morell J.P. Redorta Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: A comparative study Eur Urol 14 1988 360
50. F.M. Rommel V.E. Augusta J.A. Breslin The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice J Urol 151 1994 88
51. E. Seaman M. Whang C.A. Olsson PSA Density (PSAD): Role in patient evaluation and management Urol Clin North Am 20 1993 653
52. G.F. Sensabaugh Isolation and characterization of a semen-specific protein from human seminal plasma: A potential new marker for semen identification J Forensic Sci 23 1978 106
53. P.D. Sershon M.J. Barry J.E. Oesterling Serum PSA values in men with histologically confirmed BPH versus patients with organ-confined prostate cancer [abstract] J Urol 149 1993 421A
54. K. Shinohara S. Wolf P. Narayan Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications J Urol 152 1994 120
55. T.A. Stamey N. Yang A.R. Hay Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate N Engl J Med 317 1987 909
56. U.H. Stenman J. Leinonen H. Alfthan A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in the serum of patients with prostate cancer Cancer Res 51 1991 222
57. S. Veneziano P. Pavlica R. Querze Correlation between prostate specific antigen and prostate volume, evaluated by transrectal ultrasonography: Usefulness in the diagnosis of prostate cancer Eur Urol 18 1990 112
58. M.C. Wang I.A. Valenzuela G.P. Murphy Purification of a human prostate specific antigen Investig Urol 17 1979 159
59. R.L. Waterhouse M.I. Resnick The use of transrectal prostatic ultrasonography in the evaluation of patients prostatic carcinoma J Urol 141 1989 233
60. J.M. Wollf W. Boeckmann P.J. Effert Evaluation of patients with diseases of the prostate using prostate-specific antigen density Br J Urol 76 1995 41
61. P.G. Zentner L.K. Pao M.C. Benson Prostate specific antigen density: A new prognostic indicator for prostate cancer Int J Radiat Oncol Biol Phys 27 1993 47